The University of Pennsylvania (Penn) Telehealth Research Center of Excellence (Penn TRACE), based at the Penn Center for Cancer Care Innovation (PC3I) at the Abramson Cancer Center, is one of four National Cancer Institute (NCI) Telehealth Research Centers of Excellence dedicated to advancing the nation’s telehealth research agenda focused on improving cancer-related care and outcomes. With support from the White House Cancer Moonshot, Penn TRACE applies insights from communication science and behavioral economics to design and test innovative telehealth approaches to improve effectiveness and equity across the cancer care continuum, with an emphasis on advancing health equity and addressing the digital divide.
Learn more about Penn TRACE.
For a novel investigation into a common and deadly form of liver cancer, PC3I Innovation Fellow Timothy Brown, MD, recently received an ASCO Conquer Cancer Merit Award.
For her work leading innovative research into racial disparities in breast cancer care, Sara Ginzberg, MD, recently received a Clinical Scholar Award from the San Antonio Breast Cancer Symposium.
Four Penn Center for Cancer Care Innovation (PC3I) Faculty will be presenting the latest advances in blood cancer research and treatment at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition.